SIGLECL1 Activators
SIGLECL1 can influence the protein's activity through pathways involving the modulation of cyclic AMP (cAMP) levels within cells. Epinephrine, isoproterenol, and dopamine interact with specific adrenergic receptors on the cell surface. Upon binding to these receptors, a cascade is triggered that increases cAMP production via the activation of adenylate cyclase. Forskolin, on the other hand, bypasses receptor activation and directly stimulates adenylate cyclase, leading to a rise in cAMP. Increased cAMP levels activate protein kinase A (PKA), an enzyme that plays a crucial role in the phosphorylation of target proteins, including those associated with SIGLECL1. Cholera toxin also elevates cAMP by permanently activating the Gs alpha subunit, which continuously stimulates adenylate cyclase, subsequently elevating PKA activity. Furthermore, PGE2 and adenosine, by engaging with their respective G-protein coupled receptors, and PACAP, through activation of the PAC1 receptor, contribute to the rise in cAMP, thereby fostering an environment conducive to PKA-mediated phosphorylation processes linked to SIGLECL1.
Histamine and glucagon also promote the formation of cAMP through their interaction with G-protein coupled receptors that stimulate adenylate cyclase. On the flip side, IBMX and rolipram serve to maintain elevated levels of cAMP by inhibiting phosphodiesterases, the enzymes responsible for cAMP breakdown. This inhibition ensures that PKA remains active. The continuous activation of PKA is critical, as it is responsible for the phosphorylation of proteins involved in the SIGLECL1 activation pathway. Through these diverse but interconnected mechanisms, chemical activators ensure sustained activation of PKA, which in turn can lead to the phosphorylation and consequent modulation of SIGLECL1 activity. Each activator, despite having different modes of action, converges on a common pathway that centers around the regulation of cAMP and the activation of PKA, which is instrumental in the regulation of SIGLECL1.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine, through its action on adrenergic receptors, enhances the activity of cyclic AMP (cAMP). Elevated cAMP levels can activate protein kinase A (PKA) which then phosphorylates specific substrates including proteins that are potentially linked to SIGLECL1 activation. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a synthetic catecholamine that activates beta-adrenergic receptors, leading to increased cAMP and activation of PKA. PKA can then phosphorylate proteins that may be involved in SIGLECL1 activation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, which break down cAMP. By preventing cAMP degradation, IBMX indirectly increases PKA activation, potentially impacting proteins in the SIGLECL1 signaling pathway. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) interacts with its G-protein coupled receptors leading to increased intracellular cAMP levels. This can activate PKA, which might result in the activation of proteins associated with SIGLECL1 signaling. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine can activate G-protein coupled receptors which may result in the activation of adenylate cyclase, thereby increasing cAMP levels and activating PKA, potentially influencing SIGLECL1 activation through phosphorylation events. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine binds to its G-protein coupled receptors, which can lead to increased cAMP production and PKA activation. PKA may then activate proteins that are part of the SIGLECL1 signaling cascade. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Adenosine interacts with its G-protein coupled receptors to increase intracellular cAMP, thereby activating PKA. Activation of PKA could lead to phosphorylation of proteins within the SIGLECL1 pathway. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4, which degrades cAMP. By inhibiting cAMP degradation, rolipram indirectly leads to increased PKA activity which could phosphorylate and activate proteins associated with SIGLECL1 signaling. | ||||||